Jacqueline Garcia, Md

This early-phase study tests the safety of combining three drugs—navitoclax, venetoclax, and decitabine—for people with advanced myeloid blood cancers like leukemia and myelofibrosis. The goal is to find a safe dose that controls the disease. Sixteen adults aged 18 and older are …

This study is for people with high-risk blood cancers (AML, MDS, CMML) who are getting a donor stem cell transplant. Researchers want to see if adding the drug venetoclax to standard transplant preparation and to post-transplant maintenance therapy is safe and can help prevent th…